Nature Summaries and Reviews

An artificial-intelligence tool called Trial Pathfinder can run clinical-trial emulations using healthcare data from people with cancer, and can learn how to optimize trial-inclusion eligibility criteria, while maintaining patient safety.

As countries race to administer coronavirus vaccines, researchers are analysing the effects while a rash of viral variants raises concern.

Japan has turned regenerative medicine into a regulatory free-for-all. Patients across the world could pay the price.

Despite previous warnings, drug makers failed to prepare a stockpile of compounds to fight viral pandemics. Can they finally do the right thing?

An analysis of the costs of climate change caused by adding one tonne of methane to the atmosphere finds that high-income regions of the world should spend much more on efforts to lower such emissions than should low-income regions.

Biotech firm Oxitec launches controversial field test of its insects in Florida after years of opposition from residents and regulatory complications.

Mining the ocean floor could solve mineral shortages – and lead to epic extinctions in some of the most remote ecosystems on Earth.

After decades of assuming that pain works the same way in all sexes, scientists are finding that different biological pathways can produce an ‘ouch!’.

Jamie Morin sets out the elements required to track satellites and avoid crashes.

Humans are masters of dexterity. But robots are catching up.